Apixaban Impurity 136 | CAS 865887-16-7 - Request Quote
Apixaban Impurity 136
| SZ CAT No: | SZ-A062177 |
| CAS No | 865887-16-7 |
| Mol.F. | C11H12N2O3 |
| Mol.Wt. | 220.2 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 136 is chemically Ethyl 5-methoxy-1H-indazole-3-carboxylate. Apixaban Impurity 136 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 136 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 865887-16-7
Purchase 865887-16-7
Order 865887-16-7
Enquire 865887-16-7
price of 865887-16-7
865887-16-7 Supplier
865887-16-7 Manufacturer
865887-16-7 Exporter
buy high quality Apixaban Impurity 136
Purchase Apixaban Impurity 136
Apixaban Impurity 136 suppliers
Apixaban Impurity 136 manufacturers
Apixaban Impurity 136 price
Order Apixaban Impurity 136
Enquire Apixaban Impurity 136
Apixaban Impurity 136 cost
Apixaban Impurity 136 Supplier
Apixaban Impurity 136 Distributor
Apixaban Impurity 136 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 136 for ANDA Filing
Apixaban Impurity 136 for Forced Degradation Studies
Apixaban Impurity 136 Identification Standards
Apixaban Impurity 136 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.